Biosynex SA (FR:ALBIO) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Biosynex SA, a leader in health diagnostics, reported a turnover of €93 million in 2023 and has expanded its international presence with subsidiaries in the US, Europe, and Asia. Specializing in rapid tests and molecular biology, the company offers a range of diagnostic and care solutions for both professionals and the general public. With over 500 employees and operations in 95 countries, Biosynex is listed on Euronext Growth Paris and continues to innovate in the field of rapid diagnostics.
For further insights into FR:ALBIO stock, check out TipRanks’ Stock Analysis page.